Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Rolf Rau

Showing results (21-30 of 41) with videos related to

Pageof 5
Sort By:
Rheumatology and Therapy|September 20, 2023
Correction: Etanercept is Effective and Halts Radiographic Progression in Rheumatoid Arthritis and Psoriatic Arthritis: Final Results from a German Non-interventional Study (PRERA)Siegfried Wassenberg, Rolf Rau, Thilo Klopsch, et al.
Rheumatology and Therapy|October 17, 2022
Etanercept is Effective and Halts Radiographic Progression in Rheumatoid Arthritis and Psoriatic Arthritis: Final Results from a German Non-interventional Study (PRERA)Siegfried Wassenberg, Rolf Rau, Thilo Klopsch, et al.
Rheumatology and Therapy|November 29, 2023
Correction: Etanercept is Effective and Halts Radiographic Progression in Rheumatoid Arthritis and Psoriatic Arthritis: Final Results from a German Non-interventional Study (PRERA)Siegfried Wassenberg, Rolf Rau, Thilo Klopsch, et al.
Arthritis Research & Therapy|May 15, 2004
Association of a specific haplotype across the genes MMP1 and MMP3 with radiographic joint destruction in rheumatoid arthritisSylvia Dörr, Nadine Lechtenböhmer, Rolf Rau, et al.
Arthritis and Rheumatism|December 31, 2005
Association between protein tyrosine phosphatase 22 variant R620W in conjunction with the HLA-DRB1 shared epitope and humoral autoimmunity to an immunodominant epitope of cartilage-specific type II collagen in early rheumatoid arthritisHarald Burkhardt, Ulrike Hüffmeier, Bernd Spriewald, et al.
Arthritis Research & Therapy|January 13, 2010
Risk of incident or recurrent malignancies among patients with rheumatoid arthritis exposed to biologic therapy in the German biologics register RABBITAnja Strangfeld, Franka Hierse, Rolf Rau, et al.
Arthritis Research & Therapy|April 8, 2006
Clinical and functional remission: even though biologics are superior to conventional DMARDs overall success rates remain low--results from RABBIT, the German biologics registerJoachim Listing, Anja Strangfeld, Rolf Rau, et al.
Trials|October 29, 2014
Hydroxychloroquine in patients with inflammatory and erosive osteoarthritis of the hands (OA TREAT): study protocol for a randomized controlled trialJacqueline Detert, Pascal Klaus, Joachim Listing, et al.
Patient Preference and Adherence|March 29, 2018
A 4-year non-randomized comparative phase-IV study of early rheumatoid arthritis: integrative anthroposophic medicine for patients with preference against DMARDs versus conventional therapy including DMARDs for patients without preferenceHarald J Hamre, Van N Pham, Christian Kern, et al.
The Journal of Rheumatology|June 2, 2004
Variability of precision in scoring radiographic abnormalities in rheumatoid arthritis by experienced readersJohn T Sharp, Frederick Wolfe, Marissa Lassere, et al.
Pageof 5

Showing results (21-30 of 41) with videos related to

Sort By:
Pageof 5
Rheumatology and Therapy|September 20, 2023
Correction: Etanercept is Effective and Halts Radiographic Progression in Rheumatoid Arthritis and Psoriatic Arthritis: Final Results from a German Non-interventional Study (PRERA)Siegfried Wassenberg, Rolf Rau, Thilo Klopsch, et al.
Rheumatology and Therapy|October 17, 2022
Etanercept is Effective and Halts Radiographic Progression in Rheumatoid Arthritis and Psoriatic Arthritis: Final Results from a German Non-interventional Study (PRERA)Siegfried Wassenberg, Rolf Rau, Thilo Klopsch, et al.
Rheumatology and Therapy|November 29, 2023
Correction: Etanercept is Effective and Halts Radiographic Progression in Rheumatoid Arthritis and Psoriatic Arthritis: Final Results from a German Non-interventional Study (PRERA)Siegfried Wassenberg, Rolf Rau, Thilo Klopsch, et al.
Arthritis Research & Therapy|May 15, 2004
Association of a specific haplotype across the genes MMP1 and MMP3 with radiographic joint destruction in rheumatoid arthritisSylvia Dörr, Nadine Lechtenböhmer, Rolf Rau, et al.
Arthritis and Rheumatism|December 31, 2005
Association between protein tyrosine phosphatase 22 variant R620W in conjunction with the HLA-DRB1 shared epitope and humoral autoimmunity to an immunodominant epitope of cartilage-specific type II collagen in early rheumatoid arthritisHarald Burkhardt, Ulrike Hüffmeier, Bernd Spriewald, et al.
Arthritis Research & Therapy|January 13, 2010
Risk of incident or recurrent malignancies among patients with rheumatoid arthritis exposed to biologic therapy in the German biologics register RABBITAnja Strangfeld, Franka Hierse, Rolf Rau, et al.
Arthritis Research & Therapy|April 8, 2006
Clinical and functional remission: even though biologics are superior to conventional DMARDs overall success rates remain low--results from RABBIT, the German biologics registerJoachim Listing, Anja Strangfeld, Rolf Rau, et al.
Trials|October 29, 2014
Hydroxychloroquine in patients with inflammatory and erosive osteoarthritis of the hands (OA TREAT): study protocol for a randomized controlled trialJacqueline Detert, Pascal Klaus, Joachim Listing, et al.
Patient Preference and Adherence|March 29, 2018
A 4-year non-randomized comparative phase-IV study of early rheumatoid arthritis: integrative anthroposophic medicine for patients with preference against DMARDs versus conventional therapy including DMARDs for patients without preferenceHarald J Hamre, Van N Pham, Christian Kern, et al.
The Journal of Rheumatology|June 2, 2004
Variability of precision in scoring radiographic abnormalities in rheumatoid arthritis by experienced readersJohn T Sharp, Frederick Wolfe, Marissa Lassere, et al.
Pageof 5